[IOICORP] YoY TTM Result on 30-Jun-2003 [#4]

Stock
[IOICORP] IOI CORPORATION BHD
Announcement Date
15-Aug-2003
Admission Sponsor
-
Sponsor
-
Financial Year
30-Jun-2003
Quarter
30-Jun-2003 [#4]
Profit Trend
QoQ- 8.74%
YoY- 44.89%
Quarter Report
Latest QR
Upcoming QR
IOICORP's Result
IOICORP's Financial Summary
View:
Show?
TTM Result
30/06/06 30/06/05 30/06/04 30/06/03 30/06/02 30/06/01 30/06/00 CAGR
Revenue 6,109,668 6,072,507 4,993,454 3,907,871 2,410,500 1,337,858 1,306,685 29.29%
PBT 1,152,873 1,220,854 1,112,045 812,626 569,310 468,669 501,647 14.86%
Tax -196,158 -271,611 -410,495 -280,574 -222,809 -166,467 -198,614 -0.20%
NP 956,715 949,243 701,550 532,052 346,501 302,202 303,033 21.10%
-
NP to SH 829,002 902,220 701,550 502,052 346,501 302,202 303,033 18.25%
-
Tax Rate 17.01% 22.25% 36.91% 34.53% 39.14% 35.52% 39.59% -
Total Cost 5,152,953 5,123,264 4,291,904 3,375,819 2,063,999 1,035,656 1,003,652 31.32%
-
Net Worth 5,914,266 4,613,914 4,026,068 3,103,138 2,817,557 2,443,795 2,151,373 18.34%
Dividend
30/06/06 30/06/05 30/06/04 30/06/03 30/06/02 30/06/01 30/06/00 CAGR
Div 369,294 391,802 275,301 195,591 130,008 147,223 84,238 27.91%
Div Payout % 44.55% 43.43% 39.24% 38.96% 37.52% 48.72% 27.80% -
Equity
30/06/06 30/06/05 30/06/04 30/06/03 30/06/02 30/06/01 30/06/00 CAGR
Net Worth 5,914,266 4,613,914 4,026,068 3,103,138 2,817,557 2,443,795 2,151,373 18.34%
NOSH 1,182,853 1,117,170 1,127,750 1,041,321 883,246 839,792 840,380 5.85%
Ratio Analysis
30/06/06 30/06/05 30/06/04 30/06/03 30/06/02 30/06/01 30/06/00 CAGR
NP Margin 15.66% 15.63% 14.05% 13.61% 14.37% 22.59% 23.19% -
ROE 14.02% 19.55% 17.43% 16.18% 12.30% 12.37% 14.09% -
Per Share
30/06/06 30/06/05 30/06/04 30/06/03 30/06/02 30/06/01 30/06/00 CAGR
RPS 516.52 543.56 442.78 375.28 272.91 159.31 155.49 22.13%
EPS 70.08 80.76 62.21 48.21 39.23 35.99 36.06 11.70%
DPS 31.22 35.00 24.41 18.78 14.72 17.50 10.00 20.88%
NAPS 5.00 4.13 3.57 2.98 3.19 2.91 2.56 11.79%
Adjusted Per Share Value based on latest NOSH - 1,041,321
30/06/06 30/06/05 30/06/04 30/06/03 30/06/02 30/06/01 30/06/00 CAGR
RPS 97.63 97.03 79.79 62.45 38.52 21.38 20.88 29.29%
EPS 13.25 14.42 11.21 8.02 5.54 4.83 4.84 18.26%
DPS 5.90 6.26 4.40 3.13 2.08 2.35 1.35 27.85%
NAPS 0.9451 0.7373 0.6433 0.4959 0.4502 0.3905 0.3438 18.34%
Price Multiplier on Financial Quarter End Date
30/06/06 30/06/05 30/06/04 30/06/03 30/06/02 30/06/01 30/06/00 CAGR
Date 30/06/06 30/06/05 30/06/04 30/06/03 28/06/02 29/06/01 30/06/00 -
Price 2.86 2.10 1.63 1.14 1.22 0.53 0.60 -
P/RPS 0.55 0.39 0.37 0.30 0.45 0.33 0.39 5.89%
P/EPS 4.08 2.60 2.62 2.36 3.11 1.47 1.66 16.16%
EY 24.51 38.46 38.16 42.29 32.16 67.90 60.10 -13.87%
DY 10.92 16.67 14.98 16.48 12.07 33.02 16.67 -6.80%
P/NAPS 0.57 0.51 0.46 0.38 0.38 0.18 0.23 16.32%
Price Multiplier on Announcement Date
30/06/06 30/06/05 30/06/04 30/06/03 30/06/02 30/06/01 30/06/00 CAGR
Date 16/08/06 16/08/05 16/08/04 15/08/03 12/08/02 - 16/08/00 -
Price 3.32 2.24 1.55 1.18 1.21 0.00 0.64 -
P/RPS 0.64 0.41 0.35 0.31 0.44 0.00 0.41 7.70%
P/EPS 4.74 2.77 2.49 2.45 3.08 0.00 1.77 17.83%
EY 21.11 36.05 40.13 40.86 32.42 0.00 56.34 -15.08%
DY 9.40 15.63 15.75 15.92 12.16 0.00 15.63 -8.12%
P/NAPS 0.66 0.54 0.43 0.40 0.38 0.00 0.25 17.55%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment